SM-26-001: Assisted Outpatient Treatment Program
Closed
This grant is closed. A newer notice from the same program is forecast: Assisted Outpatient Treatment (SM-27-002). Status: Forecast, no dates yet. It is in our archive of Substance Abuse and Mental Health Services Adminis notices from 2026.
Substance Abuse and Mental Health Services Adminis offered grants of up to $750,000 to the applicants described in the notice. It expected to make about 16 awards worth $10.0 million in total. Applications closed on April 20, 2026.
From the official notice on Grants.gov, last changed March 6, 2026. Checked November 7, 2026.
- Award ceiling$750,000
- Total funding$10.0 million
- Expected awards16
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 6, 2026 |
|---|---|
| Deadline | April 20, 2026 |
| Archived by Grants.gov | May 20, 2026 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is statutorily limited to counties, cities, mental health systems (including mental health authorities), mental health courts, or any other entities with authority under the law of the State in which the applicant is located to implement, monitor and oversee assisted outpatient programs.
Is this a realistic fit?
- Past Assisted Outpatient Treatment awards averaged $1.6 million; this notice allows up to $750,000 per award.
- Most of the program's money (46% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to facilitate the implementation of AOT for adults with serious mental illness. Recipients are expected to implement the AOT program, working with civil courts, community partners, and other entities to support community-based treatment for adults with SMI who meet criteria for AOT.
Who has won Assisted Outpatient Treatment grants before
From fiscal 2021 to 2025, Assisted Outpatient Treatment (93.997) awarded $72.9 million across 46 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Kansas Department for Aging and Disability Services | Kansas | 1 | $4.0 million |
| City of Laredo | Texas | 1 | $4.0 million |
| Community Health Network Foundation, Inc. | Indiana | 1 | $3.2 million |
| Wellstone, Inc. | Alabama | 1 | $3.1 million |
| Administrative Office of the Trial Court | Massachusetts | 1 | $3.0 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, SM-27-002, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is SM-26-001 still open?
No. It closed on April 20, 2026. A newer notice is forecast: SM-27-002, forecast, no dates yet.
Who can apply for Assisted Outpatient Treatment Program?
Substance Abuse and Mental Health Services Adminis accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Assisted Outpatient Treatment Program?
Closed April 20, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $750,000 each. About $10.0 million in total across about 16 awards.
Who has won Assisted Outpatient Treatment grants before?
The largest recipients over five fiscal years were Kansas Department for Aging and Disability Services, City of Laredo, Community Health Network Foundation, Inc. The program made 46 awards worth $72.9 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)